Research and Markets: Global DNA Sequencing Products Market 2012-2016 with Hoffmann-La Roche Ltd., Knome Inc. and RainDance Technologies Inc. Dominating

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qvjfxt/global_dna) has announced the addition of the "Global DNA Sequencing Products Market 2012-2016" report to their offering.

TechNavio's analysts forecast the Global DNA Sequencing Products market to grow at a CAGR of 18.48 percent over the period 2012-2016. One of the key factors contributing to this market growth is the introduction of whole genome sequencing. The Global DNA Sequencing Products market has also been witnessing an increase in the number of DNA sequencing projects. However, the low adoption of genomic technology could pose a challenge to the growth of this market.

The key vendors dominating this market space are Agilent Technologies Inc., Hoffmann-La Roche Ltd., Illumina Inc., and Pacific Biosciences of California Inc.

The other vendors mentioned in the report are Genia Corp., International Business Machines Corp., Knome Inc., Life Technologies Corp., Oxford Nanopore Technologies Ltd., and RainDance Technologies Inc.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''The Global DNA Sequencing Products market has witnessed an increase in the number of acquisitions by the leading vendors recently. For instance, Illumina Inc. acquired BlueGnome Ltd. in September 2012 and Epicentre Biotechnologies Corp. in January 2011. Moreover, Agilent Technologies Inc. acquired Dako A/S in July 2012. Agilent also acquired Accelicon Technologies Inc. in February 2012. Further, Hoffmann-La Roche Ltd. acquired Verum Diagnostica GmbH in December 2011. Roche also acquired PVT Probenverteiltechnik GmbH in March 2011. The number of acquisitions is increasing and the same trend is expected to continue till 2016.''

According to the report, one of the major factors driving the Global DNA Sequencing Products market is the successful completion of the Human Genome Project (HGP). This accomplishment of the HGP has stimulated commercial improvements in the field of genomics with reference to DNA-based products.

Further, the report reveals that the low adoption of genomic technology among the biotechnology companies is expected to affect the growth of the Global DNA Sequencing Products market during the forecast period.

For more information visit http://www.researchandmarkets.com/research/qvjfxt/global_dna